Announcements Trials
Browse Landscape

Status

Completed 5Recruiting 4Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Plasma cell 1Other solid neoplasm 1

Conditions

Multiple Myeloma 1Metastatic Solid Tumor Cancers 1

Interventions

pembrolizumab 374Carboplatin 276Specimen Handling 265Nivolumab 252Magnetic Resonance Spectroscopy 244Cyclophosphamide 240Cisplatin 213Paclitaxel 206Radiotherapy 195Biopsy 171Gemcitabine 155Dexamethasone 148durvalumab 143atezolizumab 126Rituximab 120Doxorubicin 115Bevacizumab 114Lenalidomide 113Ipilimumab 111Radiation 109Docetaxel 103Pemetrexed 102Etoposide 101fludarabine 97venetoclax 95Fluorouracil 92Capecitabine 92Radiosurgery 90Prednisone 89Oxaliplatin 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × 4-amino-4'-hydroxylaminodiphenylsulfone × 1 year × Clear all
NCT06126341 2026-02-19

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

Memorial Sloan Kettering Cancer Center

Active not recruiting
49 enrolled
Plasma cell

Multiple Myeloma

NCT03667378 2025-10-28

Investigating the Impact of Proactive Palliative Care

Memorial Sloan Kettering Cancer Center

Active not recruiting
83 enrolled
Other solid neoplasm

Metastatic Solid Tumor Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡